Zobrazeno 1 - 10
of 19
pro vyhledávání: '"EORTC MELANOMA GROUP"'
Autor:
Bottomley, A., Coens, C., Mierzynska, J., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Puig, S., Ascierto, P. A., Larkin, J., Lorigan, P. C., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. J. M., Grob, J. -J., Gutzmer, R., Jamal, R., van Akkooi, A. C. J., Krepler, C., Ibrahim, N., Marreaud, S., Kicinski, M., Suciu, S., Robert, C., Eggermont, A. M. M., EORTC Melanoma Group, Lesimple, T., Maio, M., Linette, G., Mortier, L., Svane, I. M., Schachter, J., Brown, M., Hersey, P., Barrow, C., Kudchadkar, R., Dutriaux, C., Song, X., Quaglino, P., Queirolo, P., Meier, F., Stroyakovskiy, D., Guillot, B., Romero, P. L. O., Bastholt, L., Garbe, C., Grange, F., Mohr, P., Algazi, A., Bechter, O., Hernberg, M., Loquai, C., Meiss, F., Chiarion Sileni, V., Bar-Sela, G., Fitzharris, B., Saiag, P., Arnault, J. -P., Simon, J. -C., Stephens, R., Baurain, J. -F., Lebbe, C., Combemale, P., Dummer, R., Hauschild, A., Parente, P., Yamazaki, N., Milhem, M., Leccia, M. -T., Geoffrois, L., Kretschmer, L., Dunwoodie, E., Walker, J., Lotem, M., Hendler, D., Mackiewicz, A., Sekulovic, L., Dzienis, M., Hospers, G. A. P., Siano, M., Hassel, J., Corrie, P., Passos, M. -J., Levin, M., Hoeller, C., Machet, L., Hallmeyer, S., Waterston, A., Descamps, V., Kiecker, F., Aarts, M., Schmidt, H., Raimundo, A., Nyakas, M., Lacour, J. -P., Berking, C., Ferrucci, P. F., Jameson, M., Kim, K., Yokota, K., Kerger, J., Aubin, F., Groenewegen, G., Kapiteijn, H., Boehncke, W. -H., Utikal, J., Casasola, R., Marshall, E., Ferraresi, V., Richtig, E., Matkovic, S., Inozume, T., Crook, T., Mcneil, C., Kiyohara, Y., Avril, M. -F., Hein, R., Terheyden, P., Nathan, P., Aoi, J., Skytta, T., Jouary, T., Takenouchi, T., Straume, O., Martins, C., Mukhametshina, G.
Publikováno v:
Lancet. Oncology, Vol. 22, No 5 (2021) pp. 655-664
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 655-664 . https://doi.org/10.1016/S1470-2045(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
The Lancet Oncology, 22(5), 655-664. Lancet Publishing Group
Lancet Oncology, 22, 655-664
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.655-664. ⟨10.1016/S1470-2045(21)00081-4⟩
The Lancet Oncology, 22(5), 655-664. ELSEVIER SCIENCE INC
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 655-664 . https://doi.org/10.1016/S1470-2045(21)00081-4
Lancet Oncology, 22, 5, pp. 655-664
The Lancet Oncology, 22(5), 655-664. Lancet Publishing Group
Lancet Oncology, 22, 655-664
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.655-664. ⟨10.1016/S1470-2045(21)00081-4⟩
The Lancet Oncology, 22(5), 655-664. ELSEVIER SCIENCE INC
Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325-MG/KEYNOTE-054 trial in patients with resected, high-risk stage III melanoma demonstrated improved recurrence-free survival with adjuvant pembrolizumab compared w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80dc0ff7069bff303dade337b8effb2d
https://archive-ouverte.unige.ch/unige:159804
https://archive-ouverte.unige.ch/unige:159804
Autor:
Cattaruzza, Maria Sofia, Boniol, M, Bacci, S, Perata, E, Wald, L, Chignol, Mc, Autier, P, Doré, Jf, Tarsitani, Gianfranco, Osborn, John Frederick, Per, Epimel, EORTC MELANOMA GROUP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3686::cd4fa82465e73d2a5059b6a8905fa48a
http://hdl.handle.net/11573/61549
http://hdl.handle.net/11573/61549
Autor:
Bouwhuis MG, Suciu S, Collette S, Aamdal S, Kruit WH, Bastholt L, Stierner U, Salès F, Patel P, Punt CJ, Hernberg M, Spatz A, ten Hagen TL, Hansson J, Eggermont AM, EORTC Melanoma Group and the Nordic Melanoma Group
Publikováno v:
JNCI: Journal of the National Cancer Institute; 6/16/2009, Vol. 101 Issue 12, p869-877, 9p
Autor:
Hench, Juergen, Mihic-Probst, Daniela, Agaimy, Abbas, Frank, Stephan, Meyer, Peter, Hultschig, Claus, Simi, Sara, Alos, Lucia, Balamurugan, Thiagarajah, Blokx, Willeke, Bosisio, Francesca, Cappellesso, Rocco, Griewank, Klaus, Hadaschik, Eva, van Kempen, Léon, Kempf, Werner, Lentini, Maria, Mazzucchelli, Luca, Rinaldi, Gaetana, Rutkowski, Piotr, Schadendorf, Dirk, Schilling, Bastian, Szumera-Cieckiewicz, Anna, van den Oord, Joost, Mandalà, Mario, Massi, Daniela
Publikováno v:
European journal of cancer
PURPOSE: Dedifferentiated melanoma (DedM) poses significant diagnostic challenges. We aimed to investigate the clinical, histopathological and molecular features of DedM. Methylation signature (MS) and copy number profiling (CNP) were carried out in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712770c838606f4935efe49c0a1a3567
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85152888061
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85152888061
Autor:
Eggermont AM (AUTHOR), Suciu S (AUTHOR), Santinami M (AUTHOR), Testori A (AUTHOR), Kruit WH (AUTHOR), Marsden J (AUTHOR), Punt CJ (AUTHOR), Salès F (AUTHOR), Gore M (AUTHOR), Mackie R (AUTHOR), Kusic Z (AUTHOR), Dummer R (AUTHOR), Hauschild A (AUTHOR), Musat E (AUTHOR), Spatz A (AUTHOR), Keilholz U (AUTHOR), EORTC Melanoma Group (CORPORATE AUTHOR), Eggermont, Alexander M M1 (AUTHOR), Suciu, Stefan (AUTHOR), Santinami, Mario (AUTHOR)
Publikováno v:
Lancet. 7/12/2008, Vol. 372 Issue 9633, p117-126. 10p.
Autor:
Hayes AJ; Department of Academic Surgery, Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. Electronic address: Andrew.Hayes@rmh.nhs.uk., Coker DJ; Department of Academic Surgery, Royal Marsden Hospital, London, UK; Department of Surgery, Royal Prince Alfred Hospital, Sydney, Australia; The University of Sydney, Sydney, Australia. Electronic address: drdavidjcoker@gmail.com., Been L; Department of Surgical Oncology University Medical Center Groningen, University of Groningen, the Netherlands., Boecxstaens VW; Department of Surgical Oncology, University Hospitals Leuven, Belgium., Bonvalot S; Department of Surgery, Institute Curie, Paris, France., De Cian F; Policlinico San Martino, University of Genoa, Genoa, Italy Clinical Oncology Department; Italy Clinical Oncology Department, Italy., de la Cruz-Merino L; University Hospital Virgen Macarena, Seville, Spain., Duarte C; Department of Surgical Oncology, Instituto Nacional de Cancerología, Bogota, Colombia., Eggermont A; University Medical Center Utrecht and Princess Maxima Center, Utrecht, the Netherlands; Comprehensive Cancer Center München, Technical University München & Ludwig Maximilian University, Munich, Germany., Farricha V; Melanoma and Sarcoma Unit, Department of Surgery, Portuguese Institute of Oncology, Lisbon, Portugal., Fiore M; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Grünhagen D; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC, Rotterdam, the Netherlands., Grützmann R; Department of General and Visceral Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany., Honoré C; Sarcoma Unit, Department of Cancer Medicine, Gustave Roussy Cancer Campus, 114, Rue Edouard Vaillant, Villejuif, France., Jakob J; Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center University of Heidelberg, Mannheim, Germany., Hocevar M; Institute of Oncology Ljubljana, Slovenia., van Houdt W; Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands., Klauzner J; Surgical Oncology- Melanoma, Division of Surgery, Sourasky Tel Aviv Medical Center (Ichilov Hospital), Tel Aviv University, Israel., Kettelhack C; Clarunis, University Center for Gastrointestinal and Liver Disease Basel, Basel, Switzerland., Märten A; Belpharma s.a., Luxembourg, Luxembourg., Martinez-Said H; Deputy Direction of Surgical Oncology, Instituto Nacional de Cancerología, Mexico., Matter M; Institut Bergonié Sarcoma Unit, '229 cours de l'Argonne, 33000, Bordeaux, France., Michot A; Lausanne University Hospital and University of Lausanne Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1011, Lausanne CHUV, Switzerland., Niethard M; Department of Orthopedic Oncology, Helios Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany., Pennacchioli E; IRCSS Istituto Europeo di Oncologia, Milan, Italy., Podleska LE; Department of Orthopaedic Oncology and Soft Tissue Sarcoma, Essen University Hospital, Hufelandstraße 55, 45147 Essen, Germany., Rabago G; Department of Cardiovascular Surgery Clinica University of Navarra, Pamplona, Spain., Rastrelli M; Department of Surgery, Oncology and Gastroenterology-DISCOG, University of Padua, Padua, Italy; Department of Surgery, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Reijers S; Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, the Netherlands., Ribeiro M; Instituto Português De Oncologia De Porto, 4200 Porto, Portugal., Schwarzbach M; Varisano Klinikum Frankfurt Höchst, Frankfurt, Germany., Snow HA; Peter MacCallum Cancer Centre, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Spacek M; Second Department of Surgery-Department of Cardiovascular Surgery, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic., Stoldt S; Department of Abdominal and Paediatric Surgery, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Testori A; Chairman surgical subgroup EORTC Melanoma Group, Brussels, Belgium; Direttore divisione dermatologia Oncologica, Image Institute, Milan, Italy., Zoras O; Emeritus Professor of Surgical Oncology, University of Crete, Greece., Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Jun; Vol. 50 (6), pp. 108050. Date of Electronic Publication: 2024 Mar 06.
Autor:
Castillo P; Departments of Pathology.; University of Barcelona. Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Castrejon N; Departments of Pathology.; University of Barcelona. Barcelona, Spain., Marginet M; Departments of Pathology., Massi D; Section of Anatomical Pathology, Department of Health Sciences, University of Florence. Florence, Italy.; European Organisation for Research and Treatment of Cancer (EORTC), Melanoma Group., Alamon F; Dermatology., Teixido C; Departments of Pathology.; University of Barcelona. Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Montironi C; Departments of Pathology., Garcia-Herrera A; Departments of Pathology.; University of Barcelona. Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Albero-Gonzalez R; Departments of Pathology., Matas J; Opthamology, Hospital Clinic of Barcelona, Barcelona, Spain., Puig S; University of Barcelona. Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; European Organisation for Research and Treatment of Cancer (EORTC), Melanoma Group.; Dermatology., Alos L; Departments of Pathology.; University of Barcelona. Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; European Organisation for Research and Treatment of Cancer (EORTC), Melanoma Group.
Publikováno v:
Clinical and experimental dermatology [Clin Exp Dermatol] 2024 Mar 21; Vol. 49 (4), pp. 356-363.
Autor:
Green AC; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK. Electronic address: adele.green@qimrberghofer.edu.au., Mundra PA; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK., Grant M; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK., Marais R; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK., Cook MG; Molecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK; Histopathology, Royal Surrey Hospital, Guildford, UK; Division of Clinical Medicine, University of Surrey, Guildford, Surrey, UK; Member of European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, Brussels, Belgium.
Publikováno v:
Pathology, research and practice [Pathol Res Pract] 2024 Feb; Vol. 254, pp. 155106. Date of Electronic Publication: 2024 Jan 09.
Autor:
Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. paolo.ascierto@gmail.com., Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands., Eggermont AM; University Medical Center Utrecht & Princess Maxima Center, Utrecht, The Netherlands.; Comprehensive Cancer Center München, Technical University München & Ludwig Maximiliaan University, München, Germany., Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hamid O; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Hauschild A; Department of Dermatology, University of Kiel, Kiel, Germany., Luke JJ; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, USA., Mehnert JM; Perlmutter Cancer Center of NYU Langone/NYU Grossman School of Medicine, New York, NY, USA., Sosman JA; Robert H Lurie Comprehensive Cancer Center, Northwestern University Medical Center, Chicago, IL, USA., Tawbi HA; MD Anderson Brain Metastasis Clinic UT, MD Anderson Cancer Center, Houston, TX, USA., Mandalà M; University of Perugia, Perugia, Italy., Testori A; Image regenerative clinic Milan, Italy; EORTC Melanoma Group, Brussels, Belgium., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy., Osman I; Rudolf L. Baer, NYU Langone Medical Center, New York, NY, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Apr 18; Vol. 21 (1), pp. 265. Date of Electronic Publication: 2023 Apr 18.
Autor:
Shakeel M; Northern Care Alliance NHS Group, Mayo Building, Salford Royal, Stott Lane, Salford, M6 8HD, UK., Jiyad Z; Department of Dermatology, St George's Hospital, London, UK., Grant M; Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield, SK10 4TG, Cheshire, UK., Cook MG; Department of Dermatology, St George's Hospital, London, UK.; Department of Histopathology, Royal Surrey County Hospital, Egerton Road, Guildford, GU2 7XX, UK.; Division of Clinical Medicine, University of Surrey, Guildford, UK.; Member of EORTC Melanoma Group, Brussels, Belgium., Oudit D; The Christie NHS Foundation Trust, Wilmslow Rd, Manchester, UK., Green AC; Department of Dermatology, St George's Hospital, London, UK. adele.green@qimrberghofer.edu.au.; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. adele.green@qimrberghofer.edu.au.
Publikováno v:
Archives of dermatological research [Arch Dermatol Res] 2023 Apr; Vol. 315 (3), pp. 633-636. Date of Electronic Publication: 2022 Sep 14.